Implementing Medication-Assisted Treatment Programs in Federal Healthcare Systems

Description

This keynote presentation focuses on the importance of Medication-Assisted Treatment (MAT) programs for patients with opioid use disorder and explores the benefits and limitations of implementing MAT programs in federal healthcare systems. The speaker will define the key components of MAT, describe common models used to implement MAT in a variety of practice settings, and discuss the clinical and legal requirements for pharmacists practicing in advanced clinical roles.

Pharmacist Learning Objectives

At the end of this activity, participants will be able to: 

  1. Define the components of medication assisted treatment.
  2. Describe the spectrum or treatment goals for patients with opioid use disorder Identify pharmacologic treatment options for opioid use disorder. 
  3. Discuss the benefits and limitations of implementing medication assisted treatment programs in federal healthcare systems.
  4. Illustrate the importance of medication assisted treatment programs for patients with opioid use disorder.
  5. Describe common models used to implement medication assisted treatment in a variety of practice settings.
  6. Define the clinical and legal requirements for pharmacists practicing in advanced clinical roles to provide medication assisted treatment.

 

     

Technician Learning Objectives

At the end of this activity, participants will be able to: 

  1. Define the components of medication assisted treatment.
  2. Describe the spectrum or treatment goals for patients with opioid use disorder Identify pharmacologic treatment options for opioid use disorder. 
  3. Discuss the benefits and limitations of implementing medication assisted treatment programs in federal healthcare systems.
  4. Illustrate the importance of medication assisted treatment programs for patients with opioid use disorder.
  5. Describe common models used to implement medication assisted treatment in a variety of practice settings.
  6. Define the clinical and legal requirements for pharmacists practicing in advanced clinical roles to provide medication assisted treatment.

   

        

     

 
 
 
Speakers:
Ted
Ted Hall, PharmD, RPh
Advanced Practice Pharmacist II
USPHS/IHS; Ho-Chunk Nation Health Department
 
Learning Level: Level 2
Track: Clinical Patient Care, General Session
Session Time Slot(s): 
Date: 
Tuesday, October 29
Time: 
10:30 AM - 11:30 AM
Room: 
Hilton Anatole Dallas - Chantilly Ballroom
ACPE Pharmacist: 0202-0000-19-185-L01-P
CEUs Pharmacist: .1
ACPE Pharmacy Technician: 0202-0000-19-185-L01-T
CEUs Pharmacy Technician: .1
Activity Type:
Knowledge-based